Reaction

Renal Phospholipidosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 119 reports · 3 co-occurring drugs

As of the last recalculation, Renal Phospholipidosis appears in 119 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 328.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Eplerenone20328.2328.7
Hydroxychloroquine51208.4208.5
Quinapril Hydrochloride7164.8165.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.